SIGA Technologies, Inc. is a commercial-stage pharmaceutical company based in New York, specializing in health security and the treatment of infectious diseases. Founded in 1995, the company is known for its lead product, TPOXX, an orally administered antiviral drug specifically designed to treat smallpox, a disease caused by the variola virus. In addition to smallpox, SIGA focuses on developing pharmaceutical solutions for other high-priority threats, including Ebola, dengue, and Lassa fever. The company's mission centers on creating effective biodefense countermeasures to combat lethal pathogens and enhance public health security. Most of its revenue is generated from the United States market.
Hypernix Technologies, Ltd. is an Internet software company focused on developing and launching a freeware product designed for multilateral, real-time communication among users accessing specific URLs on the web. The company has introduced an integrated communication platform called Gooey, which supports the creation of virtual communities through chat and multimedia applications. In addition to the product, Hypernix Technologies is committed to developing a home page and web portal that enhances these communication services. The company plans to market and distribute the product, provide support, and sell advertising space on its platform and website. Furthermore, it intends to sell franchises to other websites, as well as collect and sell data to publishers and data buyers. Hypernix Technologies aims to engage in various aspects of e-commerce and explore additional Internet projects related to its offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.